StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Argus Upgrades Pfizer (PFE) to Buy
January 31, 2019 6:51 AM
Argus analyst David Toung upgraded Pfizer (NYSE: PFE) from ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Upgrades
Next Articles
Pfizer (PFE) Reports Positive CHMP Opinion for Vizimpro (dacomitinib) Positive CHMP Opinion for Vizimpro (dacomitinib) for 1st-Line Treatment of Adult Patients
February 1, 2019 9:21 AM